Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.
本文特别描述了 PCNA 调节剂的组合物以及治疗或预防癌症的方法。
IDO INHIBITORS AND THERAPEUTIC USES THEREOF
申请人:Roehrig Ute
公开号:US20110112282A1
公开(公告)日:2011-05-12
Compounds of formula (I), and pharmaceutically acceptable salts thereof, in which each compound is adapted to occupy the binding site of human IDO, which comprises a large hydrophobic pocket A and a second, proximal hydrophobic pocket B, the compound comprising at least one of the following elements: (i) a large hydrophobic fragment to substantially fill pocket A in the binding site of human IDO; (ii) an atom that can coordinate to the heme iron of human IDO, (iii) a positively charged group that can form a salt-bridge with the heme 7-propionate of the human IDO; (iv) a negatively charged group that can form a salt-bridge with Arg231 of the human IDO; (v) a hydrophobic group that can form van der Waals interactions with pocket B; and (vi) one or more substituents that can hydrogen bond to Ser167 and to Gly262, and as IDO inhibitors and their therapeutic use, eg in the treatment of cancer.
PCNA INHIBITORS
申请人:City of Hope
公开号:US20210078938A1
公开(公告)日:2021-03-18
Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.
<b>Aromatic and Pseudoaromatic Non-benzenoid Systems. III. The Synthesis of Some Ten π-Electron Systems<sup>1-3</sup></b>